ProTrials Founders Named Silicon Valley 2009 Women of Influence
Mountain View, Calif. – April 8, 2009 –
ProTrials Research
, Inc.TM, a leader in the clinical research organization industry, today announced that co-founders Jodi Andrews and Inger Arum have both been honored by the Silicon Valley/San Jose Business Journal as Women of Influence in 2009. The Business Journal award honors 100 of Silicon Valley's most influential businesswomen, as nominated by their community and selected by a panel of judges. Andrews and Arum won the award based on growing ProTrials into one of the leading CROs in the Silicon Valley.
“The women listed exemplify many of the attributes that make Silicon Valley a global leader in business, philanthropy and public policy,” said Silicon Valley/San Jose Business Journal publisher James MacGregor. “The experience and skills these women demonstrate have helped to innovate and shepherd the valley to success.”
Founded in 1996 by Andrews and Arum, ProTrials has grown into a multi-million dollar establishment with a staff of more than 100 full and part-time employees. Under their leadership, the company was the first CRO in North America to manage Phase III HIV vaccine trials and continues its work in innovative research such as cardiovascular and central nervous system, infectious diseases and oncology, and transplants and vaccines.
“Recognition by this esteemed panel of judges reinforces just how important and influential ProTrials has become in the Silicon Valley life-sciences landscape and beyond,” said Andrews.
“We are honored by this award which shows that through innovation and providing unrivaled service to its customers, ProTrials has become one of the more respected and successful companies to conduct clinical trials,” said Arum.
About ProTrials Research, Inc.
Founded in 1996, ProTrials Research, Inc. is a specialized contract research organization (CRO) with regional clinical research associates and project managers based throughout North America, Canada, and Europe. The company works with clients in the pharmaceutical, biotechnology and medical device industries, providing cost-effective site monitoring, project management and associated clinical operations services. ProTrials is headquartered in Mountain View, California. For more information, visit
www.protrials.com
or call (650) 864-9180.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
